Navina Raises $55M Series C to Expand Clinical AI Platform
Deal News | Mar 25, 2025 | Grove Ventures
Navina, a company focused on AI-driven clinical intelligence for healthcare, has successfully raised $55 million in its Series C funding round. The investment was spearheaded by Goldman Sachs Asset Management and had participation from Vertex Ventures Israel, ALIVE Israel HealthTech Fund, and Grove Ventures. This new influx of capital brings Navina's total funding to $100 million, empowering it to enhance its platform that currently supports over 10,000 clinicians across 1,300 clinics. The Navina platform is designed to facilitate a shift towards value-based care by offering real-time insights and reducing cognitive load for primary care physicians, ultimately leading to improved decision-making and patient outcomes. Grove Ventures, an early supporter of Navina, expresses confidence in the company’s mission to advance healthcare technology and its transformational impact on healthcare delivery.
Sectors
- Healthcare Technology
- Venture Capital
Geography
- Israel – Both Navina and several of its investors, such as Vertex Ventures Israel and ALIVE Israel HealthTech Fund, are based in Israel, indicating significant activity within this geographic location.
Industry
- Healthcare Technology – Navina operates within the healthcare technology sector by providing innovative AI-driven solutions to improve clinical intelligence and patient outcomes.
- Venture Capital – Grove Ventures, a key participant in the investment, is a venture capital firm supporting high-growth technology companies like Navina.
Financials
- $55,000,000 – Series C funding amount raised by Navina.
- $100,000,000 – The total funding amount Navina has raised to date.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Navina | Target Company | Company | Navina is an AI-powered healthcare company focused on enhancing clinical intelligence for primary care providers. |
| Grove Ventures | Investor | Company | Grove Ventures is a venture capital firm that has been supporting Navina's growth and technological advancements. |
| Goldman Sachs Asset Management | Lead Investor | Company | Goldman Sachs Asset Management led the Series C funding round for Navina. |
| Vertex Ventures Israel | Investor | Company | Vertex Ventures Israel is one of the participants in the Series C funding round for Navina. |
| ALIVE Israel HealthTech Fund | Investor | Company | ALIVE Israel HealthTech Fund participated in Navina’s Series C funding round, supporting their healthcare technology innovations. |